427 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR α ACTIVATION COUNTERACTS INTERLEUKIN 1β INDUCED CYTOKINE PRODUCTION BY INFRAPATELLAR FAT PAD  by Clockaerts, S. et al.
S198 Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236
Table 2. Correlations between KL grading and natural antibodies
expression
BK-IgG 0.897 0.0005
DA-IgG 0.489 0.0027
HA-IgG 0.381 0.0045
PGE2-IgG 0.832 0.0001
Conclusions: Our working group has focused on the development of
immune markers which useful in the assessment of OA. Pathogenic NA
belongs mainly to the IgG isotype. IgG to inﬂammatory pain agents
would be potent diagnostic markers for OA and may play pathogenic
roles in the development of OA. Taken together (BK-IgG, DA-IgG, HA-IgG,
PGE2-IgG), our results cold promote the understanding of the role of
immunity in OA.
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Purpose: The infrapatellar fat pad (IPFP) is located in the knee joint,
closely to the cartilage and synovial layer. It contains adipocytes, nerve
ﬁbers, macrophages and other immune cells capable of producing
cytokines that can inﬂuence the osteoarthritis (OA) etiopathogenesis.
Peroxisome proliferator activated receptor a (PPARa) is a nuclear receptor
type I and member of the superfamily of ligand-dependent transcription
factors, regulating the transcription of target genes by binding retinoid
X receptor. PPARa agonists such as ﬁbrates are used in clinical practice
as lipid lowering drugs and are also known to exert anti-inﬂammatory
effects on various tissues.
We hypothesized that the IPFP is involved in the OA process by producing
cytokines and that the production can be altered by pro- and anti-
inﬂammatory stimuli.
Methods: IPFP explants of 29 OA patients were obtained during total
knee arthroplasty. The explants were cultured during 24 hours and the
supernatant was analyzed with Luminex. IPFP and synovium explants
of 5 OA patients were cultured during 48 hours with or without
IL1b and 100mM Wy-14643, a selective and potent PPARa ligand.
mRNA expression of IL1b, monocyte chemoattractant protein(MCP)1,
IL6, tumor necrosis factor(TNF)a, leptin, vascular endothelial growth
factor(VEGF), IL10, cyclo-oxygenase(COX)2 and release of TNFa, MCP1
and prostaglandin(PG)E2 were determined. We used linear mixed models
to analyze the results. To account for differences in IL1b response
between donors, we analyzed the interaction between the effect of
PPARa activation and the response to IL1b.
Results: IPFP released cytokines such as IFNg, IL4 or IL10, additional to
the ones previously described. The addition of IL1b to the IPFP explants
increased mRNA expression of cytokines, besides leptin and IL10. Analysis
of the supernatant conﬁrmed these results. Similar results were observed
for synovium, except for VEGF that was not increased by adding IL1b
(Figure 1).
Fig. 1. Averaged mRNA expression level relative to control value. White
bars represent controls and dark bars the IL1b induced explants.
*p < 0.05.
In IPFP explants, there was a signiﬁcant interaction between IL1b
response and the effect of PPARa for TNFa (p = 0.003), IL1b (p < 0.0001),
MCP1 (p =0.003), leptin (p < 0.0001), VEGF (p < 0.0001) and COX2
(p < 0.0001), indicating that the effect of PPARa activation was dependant
on the effect of IL1b. There was no interaction for IL6 (p = 0.92) and IL10
(p =0.45). These results were conﬁrmed when analyzing the supernatant.
PPARa did not decrease mRNA expression of cytokines in the synovium
explants.
Conclusions: IPFP is an important source of cytokines and their
production is increased by IL1b and decreases by a PPARa ligand.
Therefore, IPFP is an active OA joint tissue and target for potential
disease modifying drugs such as ﬁbrates.
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ANALYSIS OF ANTI-INFLAMMATORY EFFECTS OF LANSOPRAZOLE
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Purpose: Lansoprazole (LPZ) is a typical proton pump inhibitor used
in clinical practice for treatment of gastrointesutinal mucosal disorders
caused by gastric acid hypersecretion, such as gastric ulcer and reﬂux
esophagitis. Meanwhile, LPZ inhibits macrophage adhesion molecule
expression. However, for activated macrophages in which dysfunction
occurs, overproduction of inﬂammatory mediators such as nitric oxide
(NO) and prostaglandin E2 (PGE2) is involved in the pathogenesis
of many inﬂammatory diseases, including rheumatoid arthritis. The
purpose of this study is to analyze the anti-inﬂammatory effects of
LPZ on macrophages.
Methods: RAW264.7 murine macrophages were obtained from the
Riken Cell Bank (Ibaragi, Japan). The effect of LPZ on cell viability
was tested using MTT assay after addition of LPZ at concentrations
of 0, 20, 50, 100, 200, 400mM. The amount of nitrite and PGE2 was
indicated by the amount that was measured in the RAW264.7 cell
culture supernatant. RAW264.7 cells were cultured and were treated
with several concentrations of LPZ. LPS was added to the culture medium.
To evaluate whether the inhibitory effects of LPZ on LPS-induced NO and
PGE2 production were mediated by iNOS and COX-2 protein expression,
we performed Western blot analysis.
Results: When we examined the effects of LPZ on RAW cell viability,
at concentrations of 0–100mM, no effects were seen. LPZ inhibited LPS-
induced production of nitrite in a concentration-dependent manner. In
particular, LPZ at a concentration of 100mM inhibited nitrite production
to the same extent as the control. With LPS stimulation, PGE2 levels
in the culture supernatant increased, but with LPZ pretreatment at
concentrations of 50 and 100mM, PGE2 levels also decreased. Expression
of iNOS and COX-2 was also inhibited by LPZ at a concentration of
100mM.
Conclusions: Our study showed not only inhibition of NO and PGE2
production in RAW 264.7 cells stimulated with LPS, but also suppression
of iNOS and COX-2 expression. iNOS is involved closely with regulation of
the inﬂammatory response via producing NO. The rate-limiting enzyme
in PGE2 synthesis is COX-2. Based on our study results, LPZ exerts anti-
inﬂammatory effects by suppressing iNOS and COX-2 expression. LPZ
may be promising for use in many inﬂammatory diseases in which
activated macrophages play a role, such as rheumatoid arthritis.
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VITAMIN D EFFECT ON MOLECULES ASSOCIATED TO OSTEOARTHRITIS
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C. Lavalle3, V. Ortiz-Navarrete4, J.B. Kouri1. 1CINVESTAV-IPN. Infecto´mica
y Patoge´nesis Molecular, Me´xico, D. F., Mexico; 2CINVESTAV-IPN. Biolog´ıa
Celular, Me´xico, D. F., Mexico; 3UNAM. Facultad de Med., Me´xico, D. F.,
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Purpose: The aim of this study was to evaluate the effect of the vitamin
D on the TLRs, cytokines and metolloproteases expression in a rat model
of osteoarthritis (OA).
Methods: Unilateral knee menisectomy plus 1, 3, 6, 8, 10 and 20 days of
high impact exercise was performed in order to induce OA. Normal rats
were used as a control. Rats were sacriﬁced by CO2 overdose, cartilage
explants were used for immunohistoﬂuorence assay and enzymatically
isolated chondrocytes from the right femoral condyles were used for qRT-
PCR analysis. The mRNA relative levels for TLRs (TLR-1, TLR-2, TLR-4,
